Trials / Completed
CompletedNCT01012661
Evaluation of Pain With Lidocaine-Mixed Radiesse® Injectable Dermal Filler
Evaluation of Pain With the Use of Lidocaine-Mixed Radiesse® Injectable Dermal Filler for the Treatment of Nasolabial Folds
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Merz North America, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
To assess pain during nasolabial fold treatment using Radiesse® Injectable Dermal Filler mixed with lidocaine.
Detailed description
To assess pain immediately after nasolabial fold treatment with Radiesse® Injectable Dermal Filler mixed with lidocaine in one nasolabial fold compared to Radiesse® Injectable Dermal Filler without lidocaine in the contralateral nasolabial fold.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Radiesse® Injectable Dermal Filler Mixed with Lidocaine | Calcium hydroxylapatite particles suspended in an aqueous based gel carrier mixed with 2% lidocaine hydrochloride (HCl) |
| DEVICE | Radiesse® Injectable Dermal Filler without Lidocaine | Calcium hydroxylapatite particles suspended in an aqueous based gel carrier without 2% lidocaine hydrochloride (HCl) |
Timeline
- Start date
- 2008-09-01
- Primary completion
- 2008-12-01
- Completion
- 2009-01-01
- First posted
- 2009-11-13
- Last updated
- 2013-04-26
- Results posted
- 2010-01-15
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01012661. Inclusion in this directory is not an endorsement.